Pharmintech 2019: Big increase in International Participation Expected
The nutritional and biotech sectors, medical devices, personal care products and, more broadly, the entire pharmaceutical industry are the focus...
Nestle China accelerates innovation
Oriented research and development of new products to lead the new trend of nutrition and health. Nestle held the “Nestle...
AMAL Therapeutics raises CHF 33.2 Million Series B Round
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing...
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy
T3 Pharmaceuticals , a biotech company with a focus on immuno-oncology, announced it has been named “2018 Science Start-Up of...
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced that it has initiated enrollment of patients...
SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China
Sirio Pharma Co. Ltd – the global nutraceutical contract development and manufacturing organization (CDMO) announces the opening of a gummy...
FDA Approves First Drug Using the Recombinant Factor C Assay for Endotoxin Testing
Lonza announced that the recombinant Factor C Assay has been used for endotoxin testing of Eli Lilly’s Emgality™ , the...
Almac Clinical Services Wins Excellence Awards at 2018 Cold Chain Global Forum
Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to share that temperature-controlled packaging suppliers Cold Chain...
European Commission has granted Marketing Authorization for Vertex’s SYMKEVI
Vertex Pharmaceuticals Limited, announced that the European Commission has granted Marketing Authorization for SYMKEVI in a combination regimen with ivacaftor...
Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche announced that the US FDA has approved Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu,...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.